The French National Health Insurance (Assurance Maladie) has updated its presentation of myalgic encephalomyelitis, also known as chronic fatigue syndrome. It now describes this condition as a debilitating chronic illness and clarifies that it should not be considered a psychological disorder. This development represents a significant first step towards institutional recognition for patients.
The disease affects at least 200,000 adults in France and may have increased since the Covid-19 pandemic. It causes persistent exhaustion not relieved by rest, cognitive impairment, non-restorative sleep, and malaise after even minimal exertion. Its exact cause remains unknown, although it frequently appears following an infection.
A step forward that associations were waiting for
Patient associations welcome the recognition of post-exertional malaise as a core symptom, as well as the consideration of varying degrees of severity. The new information sheet emphasizes pacing, a method of adapting one's activity to available energy. It also warns against graded exercise programs, which can worsen the condition of some patients.
Currently, there is no cure for myalgic encephalomyelitis, but appropriate management can limit its progression and alleviate some symptoms. Patient associations are now calling for training for healthcare professionals, specific care pathways, and harmonized French guidelines. Many patients also hope for easier administrative recognition as a long-term illness.
Community
Comments
Write a comment
Be the first to comment on this article.